Literature DB >> 19181379

Molecular variability of FLT3/ITD mutants and their impact on the differentiation program of 32D cells: implications for the biological properties of AML blasts.

Sona Pekova1, Robert Ivanek, Michal Dvorak, Sabrina Rueggeberg, Stefan Leicht, Xinping Li, Thomas Franz, Tomas Kozak, Jiri Vrba, Vladimir Koza, Michal Karas, Jiri Schwarz, Petr Cetkovsky, Miroslav Prucha.   

Abstract

FLT3 is the most frequently mutated gene in acute myeloid leukemia (AML), with internal tandem duplications (ITDs) accounting for up to 30% of its mutations. To analyze the impact of individual ITDs on the expression profile of immature myeloid cells, we have established 32D cell lines expressing nine different FLT3/ITDs isolated from AML patients and subjected them to whole genome expression profiling and 2DE/LC/MS proteomics. Our data indicate that in comparison to the controls, FLT3/ITD-positive 32D cells exhibit less mature expression profiles resembling early hematopoietic progenitors. Moreover, our results suggest that there exist biological differences among individual ITD variants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19181379     DOI: 10.1016/j.leukres.2009.01.004

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  2 in total

Review 1.  Will FLT3 inhibitors fulfill their promise in acute meyloid leukemia?

Authors:  Keith W Pratz; Selina M Luger
Journal:  Curr Opin Hematol       Date:  2014-03       Impact factor: 3.284

2.  Internal tandem duplication of FLT3 deregulates proliferation and differentiation and confers resistance to the FLT3 inhibitor AC220 by Up-regulating RUNX1 expression in hematopoietic cells.

Authors:  Tomohiro Hirade; Mariko Abe; Chie Onishi; Takeshi Taketani; Seiji Yamaguchi; Seiji Fukuda
Journal:  Int J Hematol       Date:  2015-11-21       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.